Vaccine-Induced Humoral Immunity: Mechanisms of Induction and Idiotypic Network Interactions
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: 30 June 2026 | Viewed by 18
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue aims to gather original research and comprehensive reviews that deepen our understanding of vaccine-induced humoral immunity across all antibody isotypes. We invite contributions exploring the mechanisms that drive effective antibody responses elicited by both conventional and next-generation vaccine platforms.
We place particular emphasis on studies examining idiotypic and anti-idiotypic interactions shaped by vaccination, as well as their potential roles in immune regulation, vaccine efficacy, and safety. Submissions based on in vitro experiments, animal models, human studies, and systematic reviews are welcome. Please note that case reports will not be considered.
We especially encourage innovative, cross-disciplinary approaches that offer novel perspectives or challenge existing paradigms, with the goal of fostering a dynamic and forward-looking discussion on the complexity of vaccine-induced humoral immunity.
I look forward to your valuable contributions.
Dr. Jefferson Russo Victor
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccines
- immunoglobulin G (IgG)
- idiotypic network
- humoral immunity
- adaptive immune response
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
